SETMAR
Basic information
Region (hg38): 3:4303331-4317265
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SETMAR gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 3 | |||||
missense | 25 | 26 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region ? | 0 | |||||
non coding ? | 0 | |||||
Total | 0 | 0 | 25 | 4 | 0 |
Variants in SETMAR
This is a list of pathogenic ClinVar variants found in the SETMAR region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
3-4303393-C-G | not specified | Uncertain significance (Apr 03, 2023) | ||
3-4303398-C-T | not specified | Uncertain significance (Sep 22, 2022) | ||
3-4303413-G-A | not specified | Uncertain significance (Feb 27, 2024) | ||
3-4303437-G-A | not specified | Uncertain significance (Jun 22, 2023) | ||
3-4303485-G-A | not specified | Uncertain significance (Mar 01, 2024) | ||
3-4303486-T-G | not specified | Uncertain significance (Sep 10, 2021) | ||
3-4303494-T-G | not specified | Uncertain significance (Sep 10, 2021) | ||
3-4303521-T-G | not specified | Uncertain significance (Dec 03, 2021) | ||
3-4312933-C-G | not specified | Uncertain significance (Oct 04, 2022) | ||
3-4312961-G-A | not specified | Uncertain significance (Jan 24, 2024) | ||
3-4312980-C-T | not specified | Uncertain significance (Jun 29, 2023) | ||
3-4312998-C-T | not specified | Uncertain significance (Mar 19, 2024) | ||
3-4313174-A-G | not specified | Uncertain significance (Nov 17, 2022) | ||
3-4313201-C-T | not specified | Uncertain significance (Aug 17, 2022) | ||
3-4313220-C-T | not specified | Uncertain significance (Jul 20, 2021) | ||
3-4313238-G-C | not specified | Uncertain significance (Aug 28, 2023) | ||
3-4313274-T-C | not specified | Uncertain significance (Nov 16, 2021) | ||
3-4313306-G-A | not specified | Uncertain significance (May 28, 2024) | ||
3-4313448-G-A | not specified | Uncertain significance (Apr 26, 2023) | ||
3-4313468-A-G | not specified | Uncertain significance (May 20, 2024) | ||
3-4313483-G-A | not specified | Uncertain significance (Jan 05, 2022) | ||
3-4313504-G-A | not specified | Uncertain significance (Apr 17, 2023) | ||
3-4313574-T-G | not specified | Uncertain significance (Mar 30, 2024) | ||
3-4313580-A-T | not specified | Uncertain significance (Feb 21, 2024) | ||
3-4313581-T-C | Likely benign (Sep 01, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SETMAR | protein_coding | protein_coding | ENST00000358065 | 3 | 14264 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.000102 | 0.821 | 125629 | 2 | 95 | 125726 | 0.000386 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.263 | 362 | 376 | 0.962 | 0.0000208 | 4463 |
Missense in Polyphen | 71 | 65.409 | 1.0855 | 831 | ||
Synonymous | 0.206 | 137 | 140 | 0.978 | 0.00000813 | 1296 |
Loss of Function | 1.24 | 8 | 12.8 | 0.626 | 7.61e-7 | 175 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000799 | 0.000797 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000598 | 0.000598 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000273 | 0.000273 |
Middle Eastern | 0.000598 | 0.000598 |
South Asian | 0.00131 | 0.00124 |
Other | 0.000491 | 0.000489 |
dbNSFP
Source:
- Function
- FUNCTION: Protein derived from the fusion of a methylase with the transposase of an Hsmar1 transposon that plays a role in DNA double-strand break repair, stalled replication fork restart and DNA integration. DNA-binding protein, it is indirectly recruited to sites of DNA damage through protein-protein interactions. Has also kept a sequence-specific DNA-binding activity recognizing the 19-mer core of the 5'-terminal inverted repeats (TIRs) of the Hsmar1 element and displays a DNA nicking and end joining activity (PubMed:16332963, PubMed:16672366, PubMed:17877369, PubMed:17403897, PubMed:18263876, PubMed:22231448, PubMed:24573677, PubMed:20521842). In parallel, has a histone methyltransferase activity and methylates 'Lys-4' and 'Lys-36' of histone H3. Specifically mediates dimethylation of H3 'Lys-36' at sites of DNA double-strand break and may recruit proteins required for efficient DSB repair through non-homologous end-joining (PubMed:16332963, PubMed:21187428, PubMed:22231448). Also regulates replication fork processing, promoting replication fork restart and regulating DNA decatenation through stimulation of the topoisomerase activity of TOP2A (PubMed:18790802, PubMed:20457750). {ECO:0000269|PubMed:16332963, ECO:0000269|PubMed:16672366, ECO:0000269|PubMed:17403897, ECO:0000269|PubMed:17877369, ECO:0000269|PubMed:18790802, ECO:0000269|PubMed:20457750, ECO:0000269|PubMed:20521842, ECO:0000269|PubMed:21187428, ECO:0000269|PubMed:22231448, ECO:0000269|PubMed:24573677, ECO:0000303|PubMed:18263876}.;
- Pathway
- Lysine degradation - Homo sapiens (human);Histone Modifications
(Consensus)
Recessive Scores
- pRec
- 0.0930
Intolerance Scores
- loftool
- 0.318
- rvis_EVS
- 0.31
- rvis_percentile_EVS
- 72.6
Haploinsufficiency Scores
- pHI
- 0.0744
- hipred
- Y
- hipred_score
- 0.551
- ghis
- 0.427
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.974
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Setmar
- Phenotype
- nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); homeostasis/metabolism phenotype; growth/size/body region phenotype;
Gene ontology
- Biological process
- DNA double-strand break processing;DNA catabolic process, endonucleolytic;double-strand break repair via nonhomologous end joining;cell population proliferation;histone H3-K36 methylation;DNA integration;replication fork processing;mitotic DNA integrity checkpoint;histone H3-K4 methylation;negative regulation of cell cycle arrest;nucleic acid phosphodiester bond hydrolysis;histone H3-K36 dimethylation;positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity;positive regulation of double-strand break repair via nonhomologous end joining;negative regulation of chromosome organization
- Cellular component
- condensed chromosome;nucleus;nucleolus;site of double-strand break
- Molecular function
- single-stranded DNA endodeoxyribonuclease activity;DNA binding;double-stranded DNA binding;single-stranded DNA binding;endonuclease activity;protein binding;zinc ion binding;histone methyltransferase activity (H3-K4 specific);protein homodimerization activity;DNA topoisomerase binding;histone methyltransferase activity (H3-K36 specific)